Triptorelin is among the peptides researched in the context of the growth hormone (GH) axis. Continuous receptor occupancy initially causes a transient surge in LH/FSH/testosterone, followed by downregulation and desensitization of pituitary GnRH receptors, producing sustained gonadotropin suppression.
Used to study continuous versus pulsatile GnRH-receptor signaling and receptor downregulation kinetics, and as the reference long-acting GnRH agonist.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
We reply personally – via email or Telegram.